Lingzhi Zhao

Lingzhi Zhao

Company: NeuShen Therapeutics

Job title: Vice President


Lingzhi Zhao, PhD is a Vice President of Biology at NeuShen Therapeutics and is working to develop AAV gene therapy to tackle neurological disorders.


Panel Discussion: Overcoming Innate Immune Barriers to Effective AAV Gene Therapies 10:15 am

Exploring the latest understanding of innate AAV vector detection pathways (e.g., PRRs, TLRs, RNA sensors) Strategies specifically overcoming AAV genome sensing Proposed and demonstrated methods for directly muting immune cell activationRead more

day: Day Two

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.